These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17724538)

  • 41. Diagnostic value of CEA, CYFRA 21-1, NSE and CA 125 assay in serum and pleural effusion of patients with lung cancer.
    Wu GP; Ba J; Zhao YJ; Wang EH
    Acta Cytol; 2007; 51(4):679-80. PubMed ID: 17718156
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion.
    Xu C; Qian L; Yu L; Zhang X; Wang Q
    Biomarkers; 2015; 20(4):271-4. PubMed ID: 26301886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic Accuracy of Tumor Markers CYFRA21-1 and CA125 in the Differential Diagnosis of Ascites.
    Trapé J; Gurt G; Franquesa J; Montesinos J; Arnau A; Sala M; Sant F; Casado E; Ordeig JM; Bergos C; Vida F; Sort P; Isava Á; González M; Molina R
    Anticancer Res; 2015 Oct; 35(10):5655-60. PubMed ID: 26408739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules].
    Ni LF; Liu XM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):707-10. PubMed ID: 25331391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic value of tumour markers in pleural effusions.
    Volarić D; Flego V; Žauhar G; Bulat-Kardum L
    Biochem Med (Zagreb); 2018 Feb; 28(1):010706. PubMed ID: 29472801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
    Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
    Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, and cytokeratin 19 fragments in patients with effusion from nonsmall cell lung cancer.
    Sharma SK; Bhat S; Chandel V; Sharma M; Sharma P; Gupta S; Sharma S; Bhat AA
    J Carcinog; 2015; 14():7. PubMed ID: 26900349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study on the value of tumor markers ProGRP, CYFRA21-1, NSE and CEA in the differential diagnosis of pleural effusion].
    Liu Y; Yu L; Lin J
    Zhongguo Fei Ai Za Zhi; 2006 Jun; 9(3):273-6. PubMed ID: 21172161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic utility of LDH, CA125 and CYFRA21-1 in tuberculosis pleural effusion.
    Lin H; Ni L
    Med Clin (Barc); 2022 Jan; 158(2):70-72. PubMed ID: 33495032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
    Gaspar MJ; De Miguel J; García Díaz JD; Díez M
    Anticancer Res; 2008; 28(5B):2947-52. PubMed ID: 19031938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The diagnostic ability of high-fluorescent cells combined with carcinoembryonic antigen for malignant pleural effusion.
    Wu W; Zhao C; Shen T; Tong X; Chen W
    Int J Lab Hematol; 2019 Aug; 41(4):509-512. PubMed ID: 31018036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.
    Porcel JM; Salud A; Vives M; Esquerda A; Rodríguez-Panadero F
    Clin Biochem; 2005 Nov; 38(11):1031-3. PubMed ID: 15925354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
    Li X; Zhang Q; Jin X; Cao L
    World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
    Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology.
    Gulyas M; Fillinger J; Kaposi AD; Molnar M
    J Clin Pathol; 2019 Aug; 72(8):529-535. PubMed ID: 31028099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Detection and diagnostic value of serum carcinoembryonic antigen and cytokeratin 19 fragment in lung cancer patients].
    Hang ZQ; Zheng MF; Huang JH
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):847-9. PubMed ID: 22335951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical value of tumor supplied group of factor combined with CEA in diagnosing tuberculosis pleural effusion and malignant pleural effusion].
    Li YP; Hu CP; Yang HZ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):608-10. PubMed ID: 15804072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of tumour markers in the diagnosis of neoplastic pleural effusion.
    San Jose ME; Alvarez D; Valdes L; Sarandeses A; Valle JM; Penela P
    Clin Chim Acta; 1997 Sep; 265(2):193-205. PubMed ID: 9385461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1.
    Son SM; Han HS; An JY; Choe KH; Lee KM; Lee KH; Kim SS; Lee YM; Lee HC; Song HG; Lee OJ
    Pathology; 2015 Feb; 47(2):123-9. PubMed ID: 25551300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reactive oxygen species modulator 1, a novel protein, combined with carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
    Chen X; Zhang N; Dong J; Sun G
    Tumour Biol; 2017 May; 39(5):1010428317698378. PubMed ID: 28459208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.